董事“火线”接盘 思创医惠迎魏乃绪入主

Core Viewpoint - The company Shichuang Medical has announced a new ownership plan, with its general manager Wei Naixu becoming the new controlling shareholder, following the termination of a previous ownership change plan. This change comes amid the company's ongoing financial struggles and legal issues related to alleged fraudulent issuance of securities [1][4]. Group 1: Ownership Change - On November 18, Shichuang Medical's stock surged to the daily limit after the announcement of the new ownership plan, with a closing price of 4.5 yuan per share, reflecting a 20% increase [2]. - The new ownership structure involves the transfer of 62.74 million shares (5.61% of total shares) from the current major shareholder to Cangnan Xinshi Enterprise Management Partnership, controlled by Wei Naixu [2][3]. - After the completion of the share transfer and voting rights delegation, Wei Naixu will indirectly hold a total of 83.47 million shares (7.47% of total shares) and have voting rights over 147 million shares (13.18% of total shares), making him the controlling shareholder [3]. Group 2: Financial Performance - Shichuang Medical has reported continuous net losses for four consecutive years, with net profits of approximately -685 million yuan, -878 million yuan, -874 million yuan, and -502 million yuan from 2021 to 2024 [4]. - In the first three quarters of this year, the company achieved a revenue of approximately 604 million yuan, a year-on-year increase of 6.95%, but still reported a net loss of about -4.76 million yuan, although this represented a 98.32% improvement compared to the previous year [4]. - The company has faced significant revenue declines due to intense industry competition and operational adjustments, leading to the divestment of its underperforming smart medical business [4]. Group 3: Legal Issues - In August, Shichuang Medical received a notice from the Hangzhou Public Security Bureau regarding an investigation into alleged fraudulent issuance of securities, which is still ongoing [5].